USANA HEALTH SCIENCES, INC.

(USNA)
  Report
Delayed Nyse  -  05/17 02:23:33 pm EDT
71.30 USD   +1.39%
05/11USANA HEALTH SCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/11USANA HEALTH SCIENCES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
05/02During National Mental Health Month, Bestselling Author/CEO Shares 5 Steps for Harmony, Balance
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

USANA Schedules Fourth Quarter and FY 2021 Earnings Release and Conference Call

01/06/2022 | 04:16pm EDT

USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter and FY 2021 results will be released after the close of market on Tuesday, February 8, 2022. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, February 9, 2022 at 11:00 a.m. Eastern Time.

The call will be broadcast over the Internet and can be accessed at http://ir.usana.com.

About USANA

USANA develops and manufactures high-quality nutritional supplements, healthy foods and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Italy, Romania, Spain, and Germany. More information on USANA can be found at www.usana.com.


ę Business Wire 2022
All news about USANA HEALTH SCIENCES, INC.
05/11USANA HEALTH SCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/11USANA HEALTH SCIENCES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
05/02During National Mental Health Month, Bestselling Author/CEO Shares 5 Steps for Harmony,..
PR
04/28USANA Releases 2021 Sustainability Report
PR
04/27TRANSCRIPT : USANA Health Sciences, Inc., Q1 2022 Earnings Call, Apr 27, 2022
CI
04/27DA Davidson Adjusts USANA Health Sciences' Price Target to $76 from $86, Keeps Neutral ..
MT
04/26USANA HEALTH : Q1 Earnings Snapshot
AQ
04/26USANA Health Sciences Earnings, Sales Decline in Fiscal Q1; Lowers FY2022 Revenue, EPS ..
MT
04/26USANA HEALTH SCIENCES : Reports First Quarter Results - Form 8-K
PU
04/26USANA HEALTH SCIENCES : Management Commentary Q1 2022
PU
More news
Analyst Recommendations on USANA HEALTH SCIENCES, INC.
More recommendations
Financials (USD)
Sales 2022 1 130 M - -
Net income 2022 102 M - -
Net cash 2022 237 M - -
P/E ratio 2022 13,3x
Yield 2022 -
Capitalization 1 349 M 1 349 M -
EV / Sales 2022 0,98x
EV / Sales 2023 0,93x
Nbr of Employees 1 978
Free-Float 58,1%
Chart USANA HEALTH SCIENCES, INC.
Duration : Period :
USANA Health Sciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends USANA HEALTH SCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 70,32 $
Average target price 81,33 $
Spread / Average Target 15,7%
EPS Revisions
Managers and Directors
Kevin G. Guest Chairman & Chief Executive Officer
Jim Brown President
G. Douglas Hekking Executive Vice President-Finance
Myron W. Wentz Chairman-Emeritus
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
USANA HEALTH SCIENCES, INC.-30.51%1 349
ZHEJIANG NHU COMPANY LTD.-21.69%9 735
BY-HEALTH CO., LTD.-28.19%4 872
THE SIMPLY GOOD FOODS COMPANY-6.47%3 902
BALCHEM CORPORATION-29.88%3 797
BELLRING BRANDS, INC.0.00%3 326